Close

Dr Anna Schultze

Research Fellow
Pharmacoepidemiology - GSK Collaboration

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Anna is a pharmacoepidemiologist who joined the Electronic Health Records Group at LSHTM in 2020. Before joining LSHTM, Anna worked as a senior research associate at the consultancy firm Evidera, where she designed and managed post-authorisation safety and comparative effectiveness studies, primarily using nationwide Scandinavian health registries. She completed a PhD in epidemiology at UCL in 2017, focusing on HIV drug resistance, and also holds an MSc in Epidemiology from LSHTM and a BSc in Human Sciences from UCL. 

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Research

Anna is interested in how we can use routinely collected data to study the effectiveness and safety of commonly used medications. Her current research focuses on the use of self-controlled designs for the analyses of clinical trial extension studies; she is also involved in a number of pharmacoepidemiological studies in COVID-19. 

Research Area
Pharmacovigilance
Primary care
Electronic health records
Methodology
Randomised controlled trials

Selected Publications

Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.
Bhaskaran K; Bacon S; Evans SJ; Bates CJ; Rentsch CT; MacKenna B; Tomlinson L; Walker AJ; Schultze A; Morton CE
2021
The Lancet regional health. Europe
Identifying Care Home Residents in Electronic Health Records - An OpenSAFELY Short Data Report
Schultze A; Bates C; Cockburn J; MacKenna B; Nightingale E; Curtis H; Hulme W; Morton C; Croker R; Bacon S
2021
COVID-19 and inhaled corticosteroids-another piece in an expanding puzzle.
Schultze A; Douglas I
2021
The Lancet. Respiratory medicine
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an analysis of 4.3 million adults over the age of 65
Schultze A; Nightingale E; Evans D; Hulme W; Rosello A; Bates C; Cockburn J; MacKenna B; Curtis HJ; Morton CE
2021
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY
The OpenSAFELY Collaborative; Walker A; MacKenna B; Inglesby P; Rentsch C; Curtis H; Morton C; Morley J; Mehrkar A; Bacon S
2021
Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.
Williamson EJ; McDonald HI; Bhaskaran K; Walker AJ; Bacon S; Davy S; Schultze A; Tomlinson L; Bates C; Ramsay M
2021
BMJ (Clinical research ed.)
See more Publications